Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

C8-Dihydroceramide

Negative control for C8 ceramide
 
BML-SL113-0005 5 mg 93.00 USD
 
BML-SL113-0025 25 mg 379.00 USD
Do you need bulk/larger quantities?
 
C8 Dihydroceramide is inactive and may be used as a negative control for C8 ceramide.

Product Details

Formula:C26H53NO3
 
MW:427.7
 
CAS:145774-33-0
 
Purity:≥98% (TLC)
 
Appearance:White waxy solid.
 
Solubility:Soluble in DMF (25 mg/ml), DMSO (5 mg/ml) or ethanol (10mg/ml).
 
Shipping:Ambient Temperature
 
Long Term Storage:-20°C
 
Regulatory Status:RUO - Research Use Only
 
BML-SL113 structure
Please mouse over
BML-SL113 structure

Product Literature References

NF-κB Signaling Negatively Regulates Osteoblast Dedifferentiation during Zebrafish Bone Regeneration: R. Mishra, et al.; Dev. Cell 52, 167 (2020), Application(s): Screening on Juvenile and adult zebrafish, Abstract;

Related Literature

Brochures
Neurodegeneration
Neurodegeneration
Download as PDF

Product Flyers
Exclusive Sphingosine Kinase 1 Inhibitor
Exclusive Sphingosine Kinase 1 Inhibitor
Download as PDF

All new literature pieces